XML 24 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
CNY (¥)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
CNY (¥)
Dec. 31, 2021
CNY (¥)
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss ¥ (531,021) $ (74,795) ¥ (768,990) ¥ (522,672)
Adjustments to reconcile net loss to net cash generated from operating activities:        
Share-based compensation (note 23)     (5,919) 14,680
Depreciation of property, plant and equipment (note 9) 82,124 11,567 88,692 64,288
Amortization of intangible assets (note 12) 36,705 5,170 34,495 30,171
Amortization of land lease payments (note 10) 9,625 1,356 9,627 9,621
Lease expense to reduce operating lease ROU 26,683 3,758 19,322 21,720
Income from equity method investments (20,789) (2,928) (17,647) (18,163)
Change in fair value of derivative liability (note 21) (5,207) (733) (1,015) 39
(Gain) loss on disposal of long-lived assets (62) (9) 3 0
Deferred tax expense (benefit) (13,039) (1,837) (71,848) 11,257
Allowance for doubtful accounts, net 64,712 9,114 5,400 2,555
Interest and consultation expenses 165,669 23,334 120,357 73,789
Loss on disposal of subsidiaries (note 4) 638 90 61,546 0
Gain on sale of partial interests in an equity method investment (37,498) (5,281) 0 0
Loss from agreements termination with a cooperative hospital     204,250 0
Changes in operating assets and liabilities net of effects of acquisition and disposals:        
Accounts receivable 36,454 5,134 644 (64,450)
Prepayments and other current assets (149,738) (21,090) (130,156) (30,908)
Inventories 44,489 6,266 (46,750) (4,352)
Other non-current assets 1,618 228 (15) (175)
Accounts payable 15,779 2,222 113,743 262,842
Accrued expenses and other liabilities 70,838 9,977 119,055 (2,515)
Deferred revenue (41,179) (5,800) 57,168 (193,464)
Income tax payable 705 99 818 (858)
Accrued unrecognized tax benefit (15,830) (2,230) (6,539) 621
Operating lease liabilities (18,147) (2,556) (2,935) (13,339)
Net cash used in operating activities (276,471) (38,944) (216,694) (359,313)
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchase of land use right     (215) 0
Investment in equity method investees     (2,300) (61,159)
Investment in equity investments without readily determinable fair value (100) (14) 0 (6,439)
Acquisitions of business, net of cash acquired     0 1,569
Acquisitions of property, plant and equipment (113,003) (15,916) (222,980) (278,977)
Acquisitions of intangible assets (4,211) (593) (818) (19,712)
Deposits for the purchases of property, plant and equipment (2,699) (380) (160,793) (481,604)
Proceeds from disposal of property, plant and equipment 310 44 5,635 212,975
Proceed from agreements termination with a cooperative hospital     238,093 0
Proceeds from principal portion of direct financing leases     7,536 31,525
Cash distribution from equity method investments 12,022 1,693 5,101 15,863
Proceeds from disposal of certain percentage of an equity method investment 60,000 8,451 0 0
Redemption of available-for-sale debt securities     11,949 19,978
Net cash used in investing activities (47,681) (6,715) (118,792) (565,981)
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from short-term bank borrowings 337,695 47,563 217,470 126,112
Proceeds from long-term bank and other borrowings 110,000 15,493 422,765 386,635
Proceeds from convertible note (note 22)       20,000
Borrowings from related parties (note 25) 22,150 3,120 220,369 24,432
Repayment to related parties (note 25) (61,777) (8,701) (82,915) (80,886)
Repayment of short-term bank and other borrowings (442,858) (62,375) (197,598) (24,706)
Repayment of long-term bank and other borrowings (7,561) (1,065) (197,003) (206,057)
Purchase of subsidiary shares from noncontrolling interests     0 (4,581)
Capital injection from a noncontrolling interests in a subsidiary 300,004 42,255   1,500
Proceeds from issuance of contingently redeemable noncontrolling interests of a subsidiary       400,000
Net cash generated from financing activities 257,653 36,290 383,088 642,449
Effect of foreign exchange rate changes on cash and cash equivalent and restricted cash (2,425) (338) (47,170) (4,639)
Net increase (decrease) in cash (68,924) (9,707) 432 (287,484)
Cash and cash equivalents and restricted cash at beginning of the year 159,343 22,443 158,911 446,395
Cash and cash equivalents and restricted cash at end of the year 90,419 12,736 159,343 158,911
Reconciliation of cash and cash equivalents and restricted cash to the consolidated balance sheets        
Cash and cash equivalents 58,139 8,189 158,283 157,386
Restricted cash, current portion 32,280 4,547 1,060 1,387
Restricted cash, noncurrent portion       138
Total cash and cash equivalents and restricted cash 90,419   159,343 158,911
Supplemental schedule of major cash flows information:        
Income tax paid (898) (126) (3,013) 0
Interest paid (152,359) (21,459) (145,257) (134,180)
Supplemental schedule of major non-cash activities:        
Acquisition of property, plant and equipment, construction in progress and other intangible assets through utilization of deposits 5,812 819 257,440 460,078
Acquisition of property, plant and equipment, construction in progress and other intangible assets included in accrued expense and other liabilities ¥ 285,358 $ 40,192 ¥ 2,181 ¥ 99,406